- Bionano Genomics schedules annual stockholder meeting for May 14, 2026 in virtual format.
- Shareholders will vote on election of two Class II directors for terms running to 2029.
- Ballot includes advisory vote on executive compensation.
- Investors will also vote on ratification of BDO USA as independent registered public accounting firm for fiscal 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionano Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001411690-26-000014), on April 02, 2026, and is solely responsible for the information contained therein.
Comments